FDA approves Sanofi and Regeneron's Dupixent for atopic dermatitis in young children
Merck predicts over 80 potential oncology approvals through 2028
Moderna's booster shot targeting both Omicron and original strain could be available by late summer
Novo Nordisk hit by age discrimination suit
*please scroll down for all the latest news*
